Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
1.
Ann Surg ; 273(6): 1066-1075, 2021 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-33214446

RESUMEN

OBJECTIVE: To evaluate the effects of the addition of preoperative hepatic and regional arterial chemotherapy (PHRAC) on prognosis of stage II and III colorectal cancer (CRC) in a multicenter setting. SUMMARY OF BACKGROUND DATA: Our previous single-center pilot trial suggested that PHRAC in combination with surgical resection could reduce the occurrence of liver metastasis (LM) and improve survival in CRC patients. METHODS: A prospective multi-center randomized controlled trial was conducted from December 2008 to December 2012 at 5 hospitals in China. Eligible patients with clinical stage II or III CRC who underwent curative resection were randomized to receive PHRAC plus adjuvant therapy (PHRAC arm) or adjuvant therapy alone (control arm). The primary endpoint was DFS. Secondary endpoints were cumulative LM rates, overall survival (OS), and safety (NCT00643877). RESULTS: A total of 688 patients from 5 centers in China were randomly assigned (1:1) to each arm. The five-year DFS rate was 77% in the PHRAC arm and 65% in the control arm (HR = 0.61, 95% CI 0.46-0.81; P = 0.001). The 5-year LM rates were 7% and 16% in the PHRAC and control arms, respectively (HR = 0.37, 95% CI 0.22-0.63; P < 0.001). The 5-year OS rate was 84% in the PHRAC arm and 76% in the control arm (HR = 0.61, 95% CI 0.43-0.86; P = 0.005). There were no significant differences regarding treatment related morbidity or mortality between the two arms. CONCLUSIONS: The addition of PHRAC could improve DFS in patients with stage II and III CRC. It reduced the incidence of LM and improved OS without compromising patient safety. TRIAL REGISTRATION: ClinicalTrials.gov identifier: NCT00643877.


Asunto(s)
Antineoplásicos/administración & dosificación , Neoplasias Colorrectales/tratamiento farmacológico , Neoplasias Colorrectales/cirugía , Adulto , Anciano , Neoplasias Colorrectales/patología , Terapia Combinada , Femenino , Arteria Hepática , Humanos , Masculino , Persona de Mediana Edad , Terapia Neoadyuvante , Estadificación de Neoplasias , Pronóstico , Estudios Prospectivos , Adulto Joven
2.
World J Surg ; 36(2): 407-14, 2012 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-22102090

RESUMEN

BACKGROUND: The aim of this trial was to compare the Enhanced Recovery After Surgery (ERAS) program with conventional perioperative management in patients who underwent radical resection for colorectal cancer. METHODS: A combination of evidence-based and consensus methodology was used to develop the ERAS protocol. Five hundred ninety-seven consecutive patients who underwent elective colorectal resection were randomized to either the ERAS (n = 299) or the control group (n = 298). Outcomes relating to nutrition and metabolism index, stress index, and recovery index were measured and recorded. RESULTS: Demographic and operative data were similar between the two groups. Patients in the ERAS group showed improved nutritional status when compared with those of the control group. On postoperative day (POD) 1, the HOMA-IR (insulin resistance index) of the ERAS group was lower than that of the control group (p < 0.001). The cortisol level of the control group was elevated on both POD 1 (p = 0.007) and POD 5 (p = 0.002) compared to the preoperative level. However, the cortisol level of the ERAS group was not increased until POD 5 (p = 0.001). Reduced levels of TNF-α, IL-1ß, IL-6, and IFN-γ in the ERAS group indicated less postoperative stress responses. In addition, ERAS was associated with accelerated recovery of gastrointestinal function. The postoperative length of stay (p < 0.001) and expense (p < 0.001) for the ERAS group were reduced in comparison to the controls. Twenty-eight cases in the control group and twenty-nine in the ERAS group suffered complications, which was not significantly different. CONCLUSION: The ERAS protocol attenuates the surgical stress response and accelerates postoperative recovery without compromising patient safety.


Asunto(s)
Colectomía , Neoplasias Colorrectales/cirugía , Atención Perioperativa/métodos , Adulto , Anciano , Anciano de 80 o más Años , China , Protocolos Clínicos , Neoplasias Colorrectales/economía , Femenino , Costos de Hospital , Humanos , Tiempo de Internación , Masculino , Persona de Mediana Edad , Estado Nutricional , Atención Perioperativa/economía , Complicaciones Posoperatorias , Estudios Prospectivos , Recuperación de la Función , Método Simple Ciego , Estrés Fisiológico , Resultado del Tratamiento
3.
Eur J Contracept Reprod Health Care ; 16(4): 277-88, 2011 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-21592009

RESUMEN

OBJECTIVES: To describe the current status of the decision-making process with regard to the use of contraceptive methods among internal migrant workers in three large Chinese cities. METHODS: A total of 4313 sexually active internal migrant workers were recruited in Beijing, Shanghai, and Chengdu. Information on contraceptive use was collected by means of questionnaires. RESULTS: Contraceptive prevalence was 86% among unmarried sexually active migrant workers and 91% among married workers. The main contraceptive methods used by married migrants were the intrauterine device (51%), condoms (25%) and female/male sterilisation (17%); the main methods resorted to by unmarried, sexually active migrants were condoms (74%) and oral contraceptives (11%). The contraceptive method applied by 20% of married respondents had been selected by other people, without they themselves having their share in an informed choice. Adopting the contraceptive decisions made by others was associated with being a married migrant, a construction or service worker, a rural-urban migrant, a migrant living in collective or rented rooms, or a migrant with more children. CONCLUSIONS: Many internal migrants in these large cities did not choose their contraceptive method on their own. Efforts enabling and encouraging migrants to make informed choices are needed.


Asunto(s)
Anticoncepción/estadística & datos numéricos , Toma de Decisiones , Migrantes , Adulto , China , Participación de la Comunidad , Condones/estadística & datos numéricos , Anticoncepción/métodos , Anticonceptivos Orales , Femenino , Humanos , Dispositivos Intrauterinos/estadística & datos numéricos , Modelos Logísticos , Masculino , Estado Civil/estadística & datos numéricos , Esterilización Reproductiva/estadística & datos numéricos , Encuestas y Cuestionarios , Lugar de Trabajo , Adulto Joven
4.
Brain Behav ; 11(8): e2232, 2021 08.
Artículo en Inglés | MEDLINE | ID: mdl-34087951

RESUMEN

OBJECTIVE: This survey aimed to assess doctors' cognition on depressive symptoms in patients with epilepsy in Shanghai China. METHODS: Questionnaires were handed out to doctors who have taken part in the epilepsy care, covering those from all third-grade hospitals and several second-grade hospitals in Shanghai China. Respondents were asked to make choices for their demographic profiles, clinical practices, acquired knowledge of, and attitudes toward the comorbidity of epilepsy and depression. RESULTS: A total of 282 questionnaires were collected from 16 hospitals in Shanghai China, of which 280 copies were included in the statistical analysis. Respondents were mainly less than 50 years (260, 92.8%), mostly residents and attendings (206, 73.6%), and mostly master and doctor's degrees (225, 80.3%). The ratio of epileptologists and nonepileptologists was 56 (20.1%):224 (79.9%). Compared to nonepileptologists and residents, epileptologists and doctors with higher professional titles were more likely to answer that they received a higher percentage of patients with the comorbidity of epilepsy and depression (≥30%), and they knew very well about the knowledge, and held the view that depression exacerbated seizures (p < .05). Surprisingly, most doctors including chief doctors and epileptologists answered that they had difficulties in prescribing antidepressants. Quite a few doctors from lower class hospitals even preferred to use tricyclic antidepressants for controlling depressive symptoms in patients with epilepsy. SIGNIFICANCE: Doctors, especially younger doctors and nonepileptologists, need more training to get knowledge of the comorbidity of epilepsy and depression. However, the therapeutic methods for depressive symptoms in patients with epilepsy were still limited and in a challenge.


Asunto(s)
Depresión , Epilepsia , China/epidemiología , Cognición , Depresión/epidemiología , Epilepsia/tratamiento farmacológico , Epilepsia/epidemiología , Humanos , Encuestas y Cuestionarios
5.
Soc Sci Med ; 63(7): 1836-45, 2006 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-16808993

RESUMEN

A major obstacle to the provision of health services is lack of an effective workforce. Human resource management (HRM) can improve the effectiveness of the workforce, though this is difficult in large bureaucratic organisations. Decentralisation is a common reform strategy and this paper sets out to examine whether HRM would be improved in decentralised settings. Indicators were developed for three areas of HR outcome: (i) appropriate staff numbers, with (ii) appropriate skills and experience, providing, (iii) appropriate inputs to organisational performance. An attempt was made to link these human resource (HR) outcomes to relevant HRM actions in two counties--one richer and one poorer--in Fujian Province, China. One general county hospital and 5 township health centres were selected for study in each country. A health facility-based survey collected information on characteristics of the workforce and staff surveys identified changes in the management of human resources and staff inputs to performance before and after decentralisation. Whilst some benefits were identified from decentralising HRM, the complexity of the decentralisation itself, and other external pressures coupled with inadequate capacity building meant that some HRM actions were not always aligned with health service objectives. Better planning and preparation coupled with strong monitoring would increase the chances of decentralisation improving HRM in the health sector.


Asunto(s)
Reforma de la Atención de Salud , Fuerza Laboral en Salud , Administración de Personal/métodos , China , Eficiencia Organizacional , Investigación sobre Servicios de Salud , Humanos , Evaluación de Resultado en la Atención de Salud , Competencia Profesional , Gestión de la Calidad Total
6.
Seizure ; 29: 26-33, 2015 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-26076841

RESUMEN

PURPOSE: The comorbidity of depression in patients with epilepsy is common and treatment is still controversial. This pilot study was aimed at evaluating the efficacy and safety of Xylaria nigripes for treating depressive symptoms in patients with epilepsy during 12 weeks of treatment. METHODS: A multicenter, double-blind, placebo-controlled, randomized superiority study was performed. A total of 104 patients with epilepsy who fulfilled the study criteria were randomized 1:1 to receive Xylaria nigripes (the Wu Ling group) or placebo (the placebo group) treatment in the 12-week period of study. The participants were visited on weeks 0, 2, 4, 8, and 12 of the treatment course. RESULTS: Eighty-one patients finished all of the visits. The primary efficacy endpoint in this study was the total effective rate for depression, which was significantly greater in the Wu Ling group (51.3%, n=39) than in the placebo group (35.7%, n=42, 0.51-0.36=0.15, 95% CI -0.06 to 0.37, U=2.83, P=0.002) after 12 weeks of treatment. No differences in seizure frequency or changes in severity were found between the Wu Ling and the placebo groups. In addition, the quality of life and seizure worry subscale scores in patients with epilepsy were also improved more notably in the Wu Ling group than in the placebo group (P<0.05). Most of the adverse effects (AEs) in this study were mild and had no differences between the Wu Ling and the placebo groups. CONCLUSION: Xylaria nigripes could alleviate depressive symptoms within 12 weeks treatment and was well tolerated in patients with epilepsy.


Asunto(s)
Antidepresivos/uso terapéutico , Trastorno Depresivo/complicaciones , Trastorno Depresivo/tratamiento farmacológico , Medicamentos Herbarios Chinos/uso terapéutico , Epilepsia/complicaciones , Adulto , Antidepresivos/efectos adversos , Comorbilidad , Trastorno Depresivo/epidemiología , Método Doble Ciego , Medicamentos Herbarios Chinos/efectos adversos , Epilepsia/epidemiología , Femenino , Humanos , Masculino , Persona de Mediana Edad , Escalas de Valoración Psiquiátrica , Calidad de Vida , Convulsiones/complicaciones , Convulsiones/epidemiología , Sueño/efectos de los fármacos , Factores de Tiempo , Resultado del Tratamiento
7.
Int J Health Plann Manage ; 19 Suppl 1: S63-78, 2004.
Artículo en Inglés | MEDLINE | ID: mdl-15686061

RESUMEN

One quarter of all TB cases occur in China, which, during the past 20 years has moved from a planned economy to a socialist market economy. In the health sector, an important proportion of the financing originates from user payment. TB control is not an exception and different programmatic models are in place. This study examines, using a case study approach, three different TB programmes, one supposed to provide free service, one subsidized service and one with full cost recovery. The aim was to better understand the driving forces for programme performance in terms of case detection, case management and patient payments. The study found for all models that control and case management approaches were, to some extent, adapted to generate maximum income to the providers. The drive for income led to fewer cases detected, administration of unnecessary procedures and drugs, and a higher than necessary cost to the patients. The latter possibly leading to exclusion of poor people from the services. If user charges are to stay, TB control programmes need to be designed to take advantage of the financial incentives to improve performance. The referral system needs to be restructured, not to provide disincentives for good practices.


Asunto(s)
Control de Enfermedades Transmisibles/economía , Tuberculosis/prevención & control , China , Control de Enfermedades Transmisibles/organización & administración , Humanos , Motivación , Política , Salud Pública , Tuberculosis/tratamiento farmacológico , Tuberculosis/economía
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA